Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to ...

Advances in genomic testing are helping doctors identify which tumours truly need chemotherapy — and which patients may do ...

A groundbreaking international trial, Optima, reveals a genomic test, Prosigna, can identify breast cancer patients unlikely ...

ASCO 2026 cancer breakthroughs from Chicago include daraxonrasib nearly doubling survival in metastatic pancreatic cancer, ...

Findings from a study of Veracyte’s Prosigna genomic assay and GRAIL’s multi-cancer early detection test were presented at ...

A genomic test could help thousands of breast cancer patients avoid chemotherapy without compromising ...

Guerdy Abraira gained a treasure trove of knowledge throughout her cancer battle. The Real Housewives of Miami star bravely let the world in on her journey to beat stage 1B estrogen-receptor-positive ...

RASolute 302 showed daraxonrasib reduced mortality risk by 60% versus chemotherapy in previously treated metastatic PDAC, with median OS 13.2 versus 6.7 months. OPTIMA found Prosigna-defined low-risk ...

The 50-gene Prosigna test identifies most patients with ER-positive, HER2-negative early breast cancer who do not benefit from adjuvant chemotherapy.

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein ...

Prosigna identified a large high-clinical-risk subgroup with minimal chemotherapy benefit, estimated to avert at most two recurrences per 100 patients treated. Enrollment broadened prior assay use by ...

MasterChef India season 1 winner Pankaj Bhadouria recently shared her diagnosis of breast cancer on Instagram. Know more about this cancer affecting many women with every passing year.